RxDoctor Payments Data

Selina Xing, MD

Pain Medicine · Wilmington, DENPI 1912986522

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $8,412 of the $13,262 with a category attached, or 63.4%. Medtronic accounts for 70.9% of it on its own, with 29 other manufacturers making up the rest. Reporting peaked in 2023 at $3,003 and has fallen 85.2% since, to $445 in 2025. Among pain medicine clinicians in DE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,262in general payments, 2019–2025

Across 345 payments — averaging $38.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$9K
  • Si-bone, Inc.$1K
  • Boston Scientific$852
  • Abbott$270
  • Nevro Corp.$220
  • Daiichi Sankyo Inc.$166
  • plus $1K from 24 others

What the payments were for

  • Travel & lodging$4,82036%
  • Food & beverage$8,41263%
  • Education$300%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,262 in reported general payments places this provider in the 90th percentile of 31 pain medicine providers in Delaware.

See all pain medicine providers in Delaware

Medicare billing

Part B allowed, 2024
$526,911
Medicare patients
761
Services billed
17,935

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin263$3,569
Tizanidine Hcl112$2,008
Lidocaine14$1,959
Meloxicam114$731
Cyclobenzaprine Hcl39$610
Celecoxib32$530
Diazepam259$328
Ibuprofen32$293
Methylprednisolone49$240
Pregabalin11$181
Tramadol Hcl12$26

Paid to pharmacies, not to this prescriber.

Other pain medicine in Wilmington

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →